Clinical Trial Update: FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing FCR (fludarabine, cyclophosphamide, rituximab) versus BR (bendamustine, rituximab) in patients with previously untreated B-cell chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine (Bendamustine)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: German CLL Study Group | Conditions: Chronic Lymphocytic Leukemia | Phase 3 | Status: COMPLETED